BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

988 related articles for article (PubMed ID: 23305254)

  • 1. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
    Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
    Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice.
    Itagaki H; Shimizu K; Morikawa S; Ogawa K; Ezaki T
    Int J Clin Exp Pathol; 2013; 6(12):2683-96. PubMed ID: 24294355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse.
    Takano K; Kaneda M; Aoki Y; Fujita N; Chiba S; Michihara S; Han LK; Takahashi R
    J Nat Med; 2024 Jun; 78(3):514-524. PubMed ID: 38498120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice.
    Susutlertpanya W; Wakuda H; Otani N; Kuramoto T; Li L; Kuranari M; Sekiguchi A; Kudo H; Uchida T; Imai H; Uemura N
    Life Sci; 2019 Jul; 228():251-257. PubMed ID: 31078545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
    Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis.
    Suga T; Yamaguchi H; Ogura J; Shoji S; Maekawa M; Mano N
    Toxicol Appl Pharmacol; 2019 Sep; 379():114664. PubMed ID: 31306673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways.
    Suzuki-Kemuriyama N; Abe A; Nakane S; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
    FEBS Open Bio; 2021 Nov; 11(11):2950-2965. PubMed ID: 34390210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
    Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.
    Suzuki-Kemuriyama N; Abe A; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
    Lipids Health Dis; 2020 Dec; 19(1):251. PubMed ID: 33317575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease.
    Toita R; Kang JH
    Toxicol Lett; 2020 Oct; 332():1-6. PubMed ID: 32579995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-restricted feeding has a limited effect on hepatic lipid accumulation, inflammation and fibrosis in a choline-deficient high-fat diet-induced murine NASH model.
    Sato T; Oishi K
    PLoS One; 2024; 19(1):e0296950. PubMed ID: 38285666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Kimura K; Inaba Y; Watanabe H; Matsukawa T; Matsumoto M; Inoue H
    J Diabetes Investig; 2019 May; 10(3):659-666. PubMed ID: 30369082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet.
    Dungubat E; Watabe S; Togashi-Kumagai A; Watanabe M; Kobayashi Y; Harada N; Yamaji R; Fukusato T; Lodon G; Sevjid B; Takahashi Y
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33353230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
    J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
    Chiba T; Suzuki S; Sato Y; Itoh T; Umegaki K
    PLoS One; 2016; 11(10):e0164191. PubMed ID: 27723801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.